NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)

他のバージョン（1件）を表示する

書誌詳細
主要な著者:	Seed, M, Betteridge, J, Caslake, M, Cooper, J, Humphries, S, Neil, A
フォーマット:	Journal article
出版事項:	2009

類似資料

NOVEL INFLAMMATORY RISK MARKERS INCLUDING LPPLA2 AND RISK OF CHD IN PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH)
著者:: Seed, M, 等
出版事項: (2009)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
著者:: Neil, A, 等
出版事項: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia
著者:: Neil, H, 等
出版事項: (2003)

Established and emerging coronary risk factors in patients with heterozygous familial hypercholesterolaemia.
著者:: Neil, H, 等
出版事項: (2004)

CURRENT STATIN TREATMENT OF PATIENTS WITH FAMILIAL HYPERCHOLESTEROLAEMIA (FH): RESULTS FROM THE ROYAL COLLEGE OF PHYSICIANS UK NATIONAL AUDIT
著者:: Seed, M, 等
出版事項: (2011)

Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk.
著者:: Humphries, SE, 等
出版事項: (2006)

Elevated lipoprotein(a) levels in Familial Hypercholesterolaemia (FH): prevalence and implications for FH clinical diagnosis
著者:: A. David, 等
出版事項: (2023-12-01)

The utility of DNA-based testing in patients with familial hypercholesterolaemia in the UK
著者:: Humphries, SE, 等
出版事項: (2005)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study
著者:: Neil, A, 等
出版事項: (2008)

Modelling a two-stage screen for autosomal dominant familial hypercholesterolaemia (FH) in UK Biobank
著者:: J. Gratton, 等
出版事項: (2022-10-01)

Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.
著者:: Neil, A, 等
出版事項: (2008)

IN APPLICABILITY OF THE CARDIOVASCULAR RISK PREDICTOR "SCORE" TO PATIENTS WITH FAMILIAL HYPERCHOLESTEROLEMIA (FH)
著者:: Descamps, O, 等
出版事項: (2010)

How many individuals with Familial Hypercholesterolaemia (FH) need to be identified to achieve the NHS 2019 Long Term Plan ambition?
著者:: S.E. Humphries, 等
出版事項: (2023-12-01)

Statins and familial hypercholesterolaemia.
著者:: Neil, A, 等
出版事項: (2009)

How many homozygous Familial Hypercholesterolaemia (FH) patients are there likely to be in the UK? : The FH phenotype caused by the APOB p.(Arg3527Trp) variant in a South Asian family
著者:: I. Tracey, 等
出版事項: (2022-10-01)

Identification of FH-causing variants in patients with clinical familial hypercholesterolaemia recruited into the 100,000 genome project: preliminary analysis
著者:: A. Rimbert, 等
出版事項: (2021-09-01)

A novel combinatorial non-viral vector to treat familial hypercholesterolaemia (FH)
著者:: Kerr, A, 等
出版事項: (2016)

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study.
著者:: Neil, H, 等
出版事項: (2003)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study.
著者:: Neil, H, 等
出版事項: (2005)

Prevalence of familial hypercholesterolaemia (FH)-causing variants and impact on LDL-C concentration in European, South Asian, and African ancestry groups of the UK Biobank
著者:: J. Gratton, 等
出版事項: (2023-12-01)

More evidence for inflammatory markers in predicting CHD risk
著者:: Lyford Joanna, 等
出版事項: (2001-03-01)

Controversies in familial hypercholesterolaemia: recommendations of the NICE Guideline Development Group for the identification and management of familial hypercholesterolaemia.
著者:: Minhas, R, 等
出版事項: (2009)

Elucigene FH20 and LIPOchip for the diagnosis of familial hypercholesterolaemia: a systematic review and economic evaluation
著者:: P Sharma, 等
出版事項: (2012-03-01)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
著者:: Marks, 等
出版事項: (2000-01-01)

Does socioeconomic status have an effect on the treatment and outcomes of individuals with familial hypercholesterolaemia (FH)? : a cohort study of individuals with FH in UK primary care
著者:: B. Iyen, 等
出版事項: (2021-09-01)

Cardiovascular disease morbidity is associated with social deprivation in subjects with familial hypercholesterolaemia (FH): a study comparing FH individuals in UK primary care and the UK Simon Broome register linked with secondary care records
著者:: B. Iyen, 等
出版事項: (2022-10-01)

Screening for hypercholesterolaemia versus case finding for familial hypercholesterolaemia: a systematic review and cost-effectiveness analysis.
著者:: Marks, D, 等
出版事項: (2000)

19. Using a novel combinatorial non-viral vector and small molecules to treat familial hypercholesterolaemia (FH)
著者:: Kerr, A, 等
出版事項: (2016)

Children and young adults with familial hypercholesterolaemia (FH) have healthier food choices particularly with respect to dietary fat sources compared with non-FH children
著者:: Ingunn Molven, 等
出版事項: (2013-01-01)

A review on the diagnosis, natural history, and treatment of familial hypercholesterolaemia.
著者:: Marks, D, 等
出版事項: (2003)

Cost effectiveness analysis of different approaches of screening for familial hypercholesterolaemia.
著者:: Marks, D, 等
出版事項: (2002)

Familial hypercholesterolaemia
著者:: D.J. Blom
出版事項: (2011-01-01)

Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.
著者:: Marks, D, 等
出版事項: (2006)

The development of a theory informed behaviour change intervention to improve adherence to dietary and physical activity treatment guidelines in individuals with familial hypercholesterolaemia (FH)
著者:: F. J. Kinnear, 等
出版事項: (2020-01-01)

Extent of underdiagnosis of familial hypercholesterolaemia in routine practice: prospective registry study.
著者:: Neil, H, 等
出版事項: (2000)

Cardiovascular Disease Risk Estimation in Mutation Confirmed Familial Hypercholesterolaemia
著者:: E. Ofagbor, 等
出版事項: (2023-12-01)

Familial hypercholesterolaemia.
著者:: Gill, P, 等
出版事項: (2012)

Effect of statin treatment for familial hypercholesterolaemia on life assurance: results of consecutive surveys in 1990 and 2002.
著者:: Neil, H, 等
出版事項: (2004)

Comparing costs and benefits over a 10 year period of strategies for familial hypercholesterolaemia screening.
著者:: Marks, D, 等
出版事項: (2003)

Reduction in cardiovascular disease morbidity of men and women with familial hypercholesterolaemia (FH) associated with availability of high intensity statins: A cohort study using data from the UK Simon Broome Register linked with secondary care records
著者:: B. Iyen, 等
出版事項: (2021-09-01)